Clayton Trier - Nov 8, 2024 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Role: Director
Signature: /s/ Clayton Trier
Stock symbol: USPH
Transactions as of: Nov 8, 2024
Transactions value $: -$191,560
Form type: 4
Date filed: 11/12/2024, 06:00 PM
Previous filing: May 21, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	USPH	Common Stock	Sale	-$192K	-2K	-23.74%	$95.78	6.42K	Nov 8, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported ($95.78) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $95.15 to $96.84 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2	Includes 712 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as 356 share in each of January 1, 2025 and April 1, 2025, if he is a director of the Company on those dates.

Content

The price reported ($95.78) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $95.15 to $96.84 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Includes 712 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as 356 share in each of January 1, 2025 and April 1, 2025, if he is a director of the Company on those dates.